Encompass Health Corporation
EHC
$107.49
-$0.59-0.55%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.59B | 1.54B | 1.48B | 1.46B | 1.46B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.59B | 1.54B | 1.48B | 1.46B | 1.46B |
| Cost of Revenue | 882.40M | 865.60M | 849.40M | 830.80M | 824.50M |
| Gross Profit | 704.20M | 679.00M | 628.10M | 626.90M | 630.90M |
| SG&A Expenses | 73.40M | 88.20M | 71.00M | 74.10M | 67.20M |
| Depreciation & Amortization | 87.30M | 86.40M | 82.40M | 79.90M | 79.20M |
| Other Operating Expenses | 241.90M | 221.00M | 231.10M | 213.80M | 217.50M |
| Total Operating Expenses | 1.29B | 1.26B | 1.23B | 1.20B | 1.19B |
| Operating Income | 301.60M | 283.40M | 243.60M | 259.10M | 267.00M |
| Income Before Tax | 288.70M | 257.70M | 219.90M | 236.80M | 238.60M |
| Income Tax Expenses | 56.40M | 55.40M | 44.90M | 51.00M | 41.60M |
| Earnings from Continuing Operations | 232.30M | 202.30M | 175.00M | 185.80M | 197.00M |
| Earnings from Discontinued Operations | 15.90M | 800.00K | -400.00K | -900.00K | -500.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -53.70M | -57.00M | -48.10M | -42.80M | -45.00M |
| Net Income | 194.50M | 146.10M | 126.50M | 142.10M | 151.50M |
| EBIT | 301.60M | 283.40M | 243.60M | 259.10M | 267.00M |
| EBITDA | 388.90M | 369.80M | 326.00M | 339.00M | 346.20M |
| EPS Basic | 1.96 | 1.45 | 1.26 | 1.41 | 1.50 |
| Normalized Basic EPS | 1.17 | 1.04 | 0.89 | 1.05 | 1.04 |
| EPS Diluted | 1.93 | 1.43 | 1.24 | 1.39 | 1.48 |
| Normalized Diluted EPS | 1.15 | 1.02 | 0.87 | 1.03 | 1.02 |
| Average Basic Shares Outstanding | 99.20M | 100.20M | 100.50M | 100.60M | 100.50M |
| Average Diluted Shares Outstanding | 100.60M | 102.00M | 102.30M | 102.30M | 102.10M |
| Dividend Per Share | 0.19 | 0.19 | 0.19 | 0.17 | 0.17 |
| Payout Ratio | 10.44% | 13.00% | 13.44% | 12.03% | 11.88% |